Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators..

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Lee HM, Koh SB.

J Mov Disord. 2015 May;8(2):92-7. doi: 10.14802/jmd.15003. Review.

Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.

Kelm-Nelson CA, Yang KM, Ciucci MR.

J Parkinsons Dis. 2015;5(4):749-63. doi: 10.3233/JPD-150688.

The genetics of Parkinson's disease.

Mullin S, Schapira A.

Br Med Bull. 2015 Jun;114(1):39-52. doi: 10.1093/bmb/ldv022. Review.

Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.

Solla P, Fasano A, Cannas A, Marrosu F.

Mov Disord. 2015 Nov;30(13):1859-60. doi: 10.1002/mds.26443. No abstract available.

Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Langner-Lemercier S, Drapier S, Naudet F, Le Clanche N, Houvenaghel JF, Sauleau P, Jannin P, Haegelen C, Le Jeune F, Vérin M.

J Neurol. 2015;262(4):881-9. doi: 10.1007/s00415-015-7647-1.

The medical treatment of Parkinson disease from James Parkinson to George Cotzias.

Fahn S.

Mov Disord. 2015 Jan;30(1):4-18. doi: 10.1002/mds.26102. Review.

[The use of piribedil in early and late stages of Parkinson's disease].

Fedorova NV, Kulua TK, Gubanova ЕN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):96-8. Russian.

[Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease].

Rodríguez-Violante M, Velázquez-Osuna S, Cervantes-Arriaga A, Corona-Vázquez T, de la Fuente-Sandoval C.

Gac Med Mex. 2015 Mar-Apr;151(2):169-75. Spanish.

Neuroimaging of Parkinson's disease: Expanding views.

Weingarten CP, Sundman MH, Hickey P, Chen NK.

Neurosci Biobehav Rev. 2015 Dec;59:16-52. doi: 10.1016/j.neubiorev.2015.09.007. Review.

Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.

Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN.

Neurology. 2015 Feb 10;84(6):609-16.

Beneficial Therapeutic Effects of Spinal Cord Stimulation in Advanced Cases of Parkinson's Disease With Intractable Chronic Pain: A Case Series.

Nishioka K, Nakajima M.

Neuromodulation. 2015 Dec;18(8):751-3. doi: 10.1111/ner.12315.

Decreased dopaminergic treatment of hospitalized Parkinson's disease patients during infectious diseases is associated with poor outcomes.

Segal O, Hassin-Baer S, Rosman M, Segal G.

J Clin Neurosci. 2015 Aug;22(8):1272-4. doi: 10.1016/j.jocn.2015.02.010.

Challenging Postural Tasks Increase Asymmetry in Patients with Parkinson's Disease.

Beretta VS, Gobbi LT, Lirani-Silva E, Simieli L, Orcioli-Silva D, Barbieri FA.

PLoS One. 2015 Sep 14;10(9):e0137722. doi: 10.1371/journal.pone.0137722.

Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.

Shine JM, Keogh R, O'Callaghan C, Muller AJ, Lewis SJ, Pearson J.

Proc Biol Sci. 2015 Jan 7;282(1798):20142047. doi: 10.1098/rspb.2014.2047.